361 related articles for article (PubMed ID: 31183523)
1. In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples.
Gaunitz F; Dahm P; Mogler L; Thomas A; Thevis M; Mercer-Chalmers-Bender K
Anal Bioanal Chem; 2019 Jun; 411(16):3561-3579. PubMed ID: 31183523
[TBL] [Abstract][Full Text] [Related]
2. Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation.
Gaunitz F; Thomas A; Fietzke M; Franz F; Auwärter V; Thevis M; Mercer-Chalmers-Bender K
Int J Legal Med; 2019 Jul; 133(4):1049-1064. PubMed ID: 30564916
[TBL] [Abstract][Full Text] [Related]
3. Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models.
Dahm P; Thomas A; Rothschild MA; Thevis M; Mercer-Chalmers-Bender K
Forensic Toxicol; 2022 Jul; 40(2):244-262. PubMed ID: 36454402
[TBL] [Abstract][Full Text] [Related]
4. Comparison between human liver microsomes and the fungus Cunninghamella elegans for biotransformation of the synthetic cannabinoid JWH-424 having a bromo-naphthyl moiety analysed by high-resolution mass spectrometry.
Watanabe S; Iwai T; Matsushita R; Nakanishi T; Kuzhiumparambil U; Fu S; Seto Y
Forensic Toxicol; 2022 Jul; 40(2):278-288. PubMed ID: 36454404
[TBL] [Abstract][Full Text] [Related]
5. Structural Elucidation of Metabolites of Synthetic Cannabinoid UR-144 by Cunninghamella elegans Using Nuclear Magnetic Resonance (NMR) Spectroscopy.
Watanabe S; Kuzhiumparambil U; Fu S
AAPS J; 2018 Mar; 20(2):42. PubMed ID: 29520690
[TBL] [Abstract][Full Text] [Related]
6. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
[TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
Yeter O; Ozturk YE
Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
[TBL] [Abstract][Full Text] [Related]
9. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
Michely JA; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans.
Watanabe S; Kuzhiumparambil U; Nguyen MA; Cameron J; Fu S
AAPS J; 2017 Jul; 19(4):1148-1162. PubMed ID: 28455676
[TBL] [Abstract][Full Text] [Related]
12. Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluation.
Giorgetti A; Mogler L; Haschimi B; Halter S; Franz F; Westphal F; Fischmann S; Riedel J; Pütz M; Auwärter V
Drug Test Anal; 2020 Jan; 12(1):78-91. PubMed ID: 31476105
[TBL] [Abstract][Full Text] [Related]
13. In vitro phase I metabolism of three phenethylamines 25D-NBOMe, 25E-NBOMe and 25N-NBOMe using microsomal and microbial models.
Grafinger KE; Stahl K; Wilke A; König S; Weinmann W
Drug Test Anal; 2018 Oct; 10(10):1607-1626. PubMed ID: 29971945
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolism of synthetic cannabinoid AM1220 by human liver microsomes and
Watanabe S; Kuzhiumparambil U; Fu S
Forensic Toxicol; 2018; 36(2):435-446. PubMed ID: 29963209
[TBL] [Abstract][Full Text] [Related]
16. Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes.
Kong TY; Kim JH; Choi WG; Lee JY; Kim HS; Kim JY; In MK; Lee HS
Anal Bioanal Chem; 2017 Feb; 409(6):1667-1680. PubMed ID: 27924364
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the NADPH-dependent metabolism of 17beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5.
Lee AJ; Kosh JW; Conney AH; Zhu BT
J Pharmacol Exp Ther; 2001 Aug; 298(2):420-32. PubMed ID: 11454902
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the metabolites of the HIF stabilizer FG-4592 (roxadustat) in five different in vitro models and in a human doping control sample using high resolution mass spectrometry.
Hansson A; Thevis M; Cox H; Miller G; Eichner D; Bondesson U; Hedeland M
J Pharm Biomed Anal; 2017 Feb; 134():228-236. PubMed ID: 27918992
[TBL] [Abstract][Full Text] [Related]
19. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood.
Watanabe S; Vikingsson S; Åstrand A; Gréen H; Kronstrand R
AAPS J; 2019 Dec; 22(1):13. PubMed ID: 31848852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
